Clinical reviewer: Dr. Sarah Boss, MD

COGNIFUL publishes this guide and is part of THE BALANCE GROUP in Mallorca, Spain. The provider examples illustrate different clinical settings, including outpatient and hospital services, rather than an independent ranking of equivalent luxury residences. International eligibility and actual treatment availability must be confirmed with each provider. [1] [2]

A thorough assessment should establish what is being used, how often, in what circumstances, and with what consequences. Include prescribed medication, alcohol, nonprescribed drugs, and any uncertainty about products. Tell the clinician about previous treatment, changes in sleep or mood, physical symptoms, and difficulties reducing use. The NHS describes drug treatment as dependent on the drugs involved and the person’s circumstances, with different forms and intensities of care. [3]

A general claim to treat addiction does not answer whether a program can manage your particular needs. Ask for the clinical pathway in plain language: what happens first, which professionals participate, what is delivered at the residence, and what requires another service. If the answer treats every substance as the same problem, ask for a more specific proposal before comparing prices.

Prescribed medication deserves careful interpretation. Physical dependence can develop with benzodiazepines even when taken as prescribed; it is not a reason to assume the same treatment history or behavior as every addiction presentation. Abrupt changes can be dangerous and require a clinician-led plan. Do not stop medication to qualify for a booking or meet a travel deadline. [4]

Acute breathing difficulty, seizures, severe chest pain, marked confusion, or an immediate psychiatric crisis call for urgent medical care. A residential inquiry should not delay that response. A provider’s ability to deliver later therapy is different from its capacity to manage intoxication, severe withdrawal, or another acute complication. Ask the assessing clinician which setting is appropriate now. [4] [5]

Opioids: establish the medication pathway

For opioid use disorder, the CDC recommends offering or arranging evidence-based medication treatment. It advises against detoxification alone without medication because this increases the risks of return to use and overdose. A provider should explain whether it delivers the relevant medication care or coordinates with another qualified service. Do not interpret a luxury residence’s general addiction description as proof that it provides this pathway. [6]

If medication is already part of treatment, discuss continuity before a change of setting. Who prescribes during the stay? What monitoring is required? Who continues care afterward? The answers need to be specific to the medication and location. Travel should not interrupt an effective clinical arrangement merely because a program favors an undifferentiated drug-free message.

Stimulants: ask about structured behavioral treatment

The ASAM/AAAP guideline identifies contingency management as a primary component of stimulant use disorder treatment, alongside other psychosocial interventions. This is a structured method of reinforcing agreed treatment behaviors. Ask whether it is offered and how it works within the proposed care. Cognitive behavioral and other structured approaches may also form part of the plan, with individual availability confirmed by the provider. [5]

Ask how mood, anxiety, sleep, and other psychiatric symptoms are assessed over time. A stimulant pathway should not reduce every need to a short period labeled detox. Symptoms and risks require ongoing review, and the team should explain what would prompt medical or psychiatric escalation. [5]

Prescription sedatives: clarify dependence and medical responsibility

If benzodiazepines or other sedating medications are involved, identify the original condition being treated and the current prescriber. Ask who will assess dependence, continued clinical need, and any proposed change. The FDA warns that rapid benzodiazepine discontinuation can cause serious withdrawal. A generic residential timetable cannot replace an individualized medical decision. [4]

Also ask how the underlying problem will be addressed. Someone prescribed medication for anxiety or sleep may need ongoing care for those symptoms whether or not the prescription changes. A coherent plan should not create a gap between substance-related work and the reason treatment was first started.

Cannabis: evaluate control and functional impact

The CDC describes cannabis use disorder through patterns such as difficulty controlling use, unsuccessful efforts to reduce it, craving, and effects on responsibilities or relationships. A clinical assessment should consider the person’s actual pattern rather than decide from legal status or product branding. Ask which psychological approaches are available and how sleep, mood, and co-occurring needs will be considered. [7]

WHO guidance identifies cognitive behavioral, motivational enhancement, and family approaches as options for cannabis dependence, while grading that recommendation as conditional with low-quality evidence. This is a reason for careful discussion of methods and goals, not a basis for guaranteed outcomes or a claim that every cannabis problem requires residential care. [8]

Use a substance-specific checklist in the admission conversation

If more than one row applies, ask how the pathways fit together. A person should not have to choose which need to disclose to match a program’s preferred description. Accurate information allows the team to identify whether coordinated care is feasible or whether a different service should lead the first stage.

An outpatient clinic may deliver an important specialist intervention without offering residential accommodation. A private residence may offer a comfortable setting without having every medical capability. Both distinctions matter. The table is designed to help you ask about treatment functions rather than presume a single hierarchy from public service to luxury facility.

Ask the assessor to explain why the proposed setting fits your needs. Outpatient, day, and residential treatment can serve different circumstances. Relevant questions include the ability to attend reliably, current health, support, and how the environment affects treatment engagement. A person does not demonstrate commitment by choosing the most restrictive or expensive setting. The recommendation should have a clinical and practical rationale. [3]

Request a proposed schedule that distinguishes assessment, individual clinical work, group or shared activities, medication review, and other sessions. A full diary is not the same thing as a defined treatment method. Ask which elements are essential to the plan and which support daily structure or comfort. This makes different programs easier to compare without dismissing the value of a humane environment.

Clarify who leads treatment decisions. If several professionals are involved, ask how they communicate and who reviews changes. For co-occurring substance use and mental health needs, a shared formulation is more useful than unrelated appointments. COGNIFUL describes coordinated consideration of co-occurring needs, but the actual professionals and services still need confirmation for the individual. [12] [13]

Ask how progress is evaluated. Useful reviews connect agreed goals with the person’s experience and clinically appropriate measures. They should inform adjustments rather than simply record attendance. Be cautious about outcome claims that do not define improvement, explain follow-up, or disclose which patients are included. A transparent process is easier to assess than a promise of permanent change.

Also ask what happens when the initial plan proves insufficient. Who makes the decision to arrange another assessment or a higher level of care? How is the person involved? Which services are external? A program that explains its boundaries provides more usable information than one that implies it can manage every possible presentation within one residence.

Ask the team to explain the proposed goals without reducing them to a slogan. The person may need to address substance use, engagement with medication care, mental health symptoms, relationships, or practical functioning. The relevant priorities should emerge from assessment. A clear goal helps explain why a particular intervention is being proposed and when it should be reconsidered.

Do not confuse comfort with lack of structure. A private suite can coexist with a demanding clinical schedule, while a less exclusive setting can provide highly specialized care. Ask what participation will involve and whether it is compatible with the work or family commitments you hope to maintain. This makes the decision about the actual treatment experience rather than an imagined retreat.

COGNIFUL is a Mallorca residential program and part of THE BALANCE GROUP. Its named addiction pathways include alcohol, cocaine, prescription drugs, and cannabis. Those published topics do not establish a specialist program for every drug or every medical complication. Admission requires a suitability assessment, and withdrawal, acute medical needs, or acute psychiatric symptoms may need another level of care first. [1] [2]

Both residential tiers accommodate a maximum of four clients at any time, with a private suite for each person. Clinical and bodywork sessions are individual. The residence, chef, and personal manager are shared in both programs. Other holistic sessions, excursions, and activities are shared in Premier; every session and activity is individual in Premier Plus. This is a precise small-residence model rather than exclusive occupancy. The client limit does not establish a staff ratio, treatment intensity, or comparative clinical result. [14]

COGNIFUL Premier and Premier Plus both include assessment, a personal plan, and continuing-care planning. Plus adds individual therapeutic work, family and transition work, and three months of aftercare. Additional follow-up for the base program is agreed individually. Typical stays are four to twelve weeks, subject to review rather than a fixed schedule for every substance. [15] [16] View program fees

A useful proposal should identify the substances and symptoms being addressed, the relevant clinicians, and the actual treatment methods. Ask explicitly about medication continuity, withdrawal assessment, or behavioral interventions important to your decision. Do not assume that a guideline recommendation or a team member’s biography confirms the same service will be included in every stay. The individual plan should state what is available. [13] [17]

COGNIFUL is self-pay and does not directly bill insurers. Obtain written confirmation of total fees, duration assumptions, inclusions, and exclusions. Discuss any external medical pathway and the receiving clinician at home. An international admission should proceed only after clinical acceptance and a realistic travel plan; continuing care must be arranged for the actual jurisdiction rather than presumed to be universally available online. [15] [18] [19]

Compare a viable domestic option with any overseas residence. Ask what treatment abroad adds and what coordination it requires. Travel can create time away from familiar routines, but it also separates the person from existing clinicians and support. A destination should be chosen because the complete plan is workable, not because distance is treated as a treatment in itself.

Language should be confirmed for assessment, therapy, consent, family work, and discharge information. A multilingual admissions desk does not guarantee that every clinical interaction will be available in the same language. Where records move between countries, agree how essential information will be understood by the receiving team.

Medication arrangements deserve advance attention. Ask the treating and receiving professionals to agree responsibilities rather than leaving the patient to interpret conflicting advice. Confirm travel-related medication questions through the relevant qualified professionals and official requirements for the actual journey. This guide does not establish cross-border prescribing rights or permission to carry every medication everywhere.

For family involvement, define a useful and consensual role. Relatives may help with practical arrangements or attend agreed sessions, but they should not become an informal replacement for clinical monitoring. Decide who receives information, what remains confidential, and how the person receiving care participates in those decisions.

The first week after treatment is a useful planning exercise. Ask which appointments are booked, how daily responsibilities resume, what support is accessible, and whom to contact if symptoms or use change. An aftercare label is meaningful when it becomes a set of actual appointments and responsibilities. COGNIFUL’s continuing-care information should be translated into that individual plan. [16]

For cost comparison, request the total expected episode rather than a weekly rate alone. Ask about assessment, any separate medical service, the planned stay, and later appointments. Confirm what is included instead of assuming that every item is either covered or additional. If one proposal recommends a substantially different duration, ask what clinical work explains that difference and how the recommendation will be reviewed.

Keep a short written record of each provider’s answers. It can help you distinguish confirmed services from possibilities still awaiting assessment. That distinction is particularly useful when a family is comparing several countries and receiving optimistic introductory descriptions from multiple admissions teams.

Bring earlier treatment experience into the comparison. Ask which elements helped, what became difficult after discharge, and how the new proposal responds to that history. A change of destination should come with an explanation of the clinical and practical changes being proposed. It should not rely on the assumption that a different setting alone will resolve the problems encountered in previous care.

Can one drug program treat every substance?

Do not assume so. Different substances can require different medication, withdrawal, behavioral, and medical pathways. Ask the provider to confirm its actual scope for your combination of needs and explain which services must be arranged elsewhere. [6] [5] [2]

Is detox the same as addiction treatment?

No. Stabilization may be needed, but ongoing treatment addresses the substance use disorder and related needs. In opioid use disorder, the CDC specifically advises against detoxification alone without medication treatment because of the associated risks. [6]

Does taking a prescribed medicine mean I need addiction rehab?

Not automatically. Assessment should distinguish the medication’s purpose, physical dependence, problematic use, and the ongoing condition being treated. Discuss changes with the prescriber; abrupt benzodiazepine discontinuation can be dangerous. [4]

How can I ask about COGNIFUL without committing to a stay?

Request a suitability review with accurate substance, medication, symptom, and treatment information. Ask for a written clinical proposal and fees, including any necessary care before admission and the plan after returning home. This allows the decision to follow the clinical assessment. [18] [15]

1. Addiction treatment at COGNIFUL — COGNIFUL
2. Clinical scope, suitability and care coordination — COGNIFUL
3. Drug addiction: getting help — NHS
4. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class — US Food and Drug Administration
5. ASAM/AAAP clinical practice guideline on the management of stimulant use disorder — American Society of Addiction Medicine and American Academy of Addiction Psychiatry
6. Opioid use disorder: treating — Centers for Disease Control and Prevention
7. Understanding your risk for cannabis use disorder — Centers for Disease Control and Prevention
8. Psychosocial interventions for cannabis dependence — World Health Organization
9. Addiction Psychiatry Clinic — UCLA Health
10. Treatment options at Jellinek — Jellinek
11. Addiction disorders and dual diagnoses — Psychiatric University Hospital Zurich
12. Co-occurring mental health and addiction needs — COGNIFUL
13. How residential treatment works at COGNIFUL — COGNIFUL
14. Life at COGNIFUL in Mallorca — COGNIFUL
15. COGNIFUL programs, fees and admissions — COGNIFUL
16. Reintegration and continuing care — COGNIFUL
17. Clinical team and care coordination — COGNIFUL
18. Professional referrals — COGNIFUL
19. Considering residential treatment in Mallorca: what to check before traveling — COGNIFUL

Source information checked October 18, 2026. Confirm current services, eligibility, fees, and availability directly with each provider.